Drug repurposing can be cheaper and faster than developing new compounds. Yet, it
remains underused, partially because of regulatory and intellectual property challenges …

Drug innovation traditionally follows a de novo approach with new molecules through a
complex preclinical and clinical pathway. In addition to this strategy, drug repositioning has …

Recent technical breakthroughs underscore the potential of second generation (2G)
quantum technologies including quantum simulation, quantum sensing and metrology …

European patent protection for medical uses of known products and drug repurposing | Nature
Biotechnology Skip to main content Thank you for visiting nature.com. You are using a browser …

Commentators claim that drug repositioning (ie developing new uses for authorised drugs)
significantly slows when generics are authorised and, therefore, law reform is necessary to …

Objectives: This study investigates the role of and methods for patent analysis in advancing
medical technology (MedTech) innovation, a sector characterized by diverse, non …

The bachelor¿ s thesis objective consists of developing a quintic spline numerical algorithm
and study its potential for solving some different bioengineering problems. The numerical …

The issues around financial and regulatory obstacles to the repurposing of off-patent/generic
medicines are well characterised in the academic literature and are familiar to policymakers …

Gentherapie biedt kansen op genezing aan ernstig zieke patiënten die voorheen vaak geen
behandelopties hadden. Maar gentherapieën behoren ook tot de duurste geneesmiddelen …

In deze signalering verkent de COGEM hoeveel nieuwe gentherapieën in de pijplijn zitten,
wat de kosten zijn, en de dilemma's en keuzes die met de komst van deze therapieën …